For: | Lin YC, Wu MY, Li DR, Wu XY, Zheng RM. Prognostic and clinicopathological features of E-cadherin, α-catenin, β-catenin, γ-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. World J Gastroenterol 2004; 10(22): 3235-3239 [PMID: 15484291 DOI: 10.3748/wjg.v10.i22.3235] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i22/3235.htm |
Number | Citing Articles |
1 |
David S. Liu, Sanne J.M. Hoefnagel, Oliver M. Fisher, Kausilia K. Krishnadath, Karen G. Montgomery, Rita A. Busuttil, Andrew J. Colebatch, Matthew Read, Cuong P. Duong, Wayne A. Phillips, Nicholas J. Clemons. Novel metastatic models of esophageal adenocarcinoma derived from FLO-1 cells highlight the importance of E-cadherin in cancer metastasis. Oncotarget 2016; 7(50): 83342 doi: 10.18632/oncotarget.13391
|
2 |
Wei Liu, Zai-Cheng Yu, Wen-Feng Cao, Fang Ding, Zhi-Hua Liu. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma. World Journal of Gastroenterology 2006; 12(24): 3929-3932 doi: 10.3748/wjg.v12.i24.3929
|
3 |
Xue Hou, Run-Bin Liang, Jin-Chang Wei, Ying Xu, Jian-Hua Fu, Rong-Zhen Luo, Jie-Hua He, Lan-Jun Zhang, Peng Lin, Hao-Xian Yang. Cyclin D1 expression predicts postoperative distant metastasis and survival in resectable esophageal squamous cell carcinoma. Oncotarget 2016; 7(21): 31088 doi: 10.18632/oncotarget.9078
|
4 |
Chunni Wang, Jingnan Wang, Zhaoli Chen, Yibo Gao, Jie He. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review. Chinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0232-5
|
5 |
Fernanda Roca, Laura V. Mauro, Ana Morandi, Fernando Bonadeo, Carlos Vaccaro, Guillermo Ojea Quintana, Sergio Specterman, Elisa Bal de Kier JoffÉ, María Guadalupe Pallotta, Lydia InÉs Puricelli, JosÉ Lastiri. Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma. Journal of Surgical Oncology 2006; 93(2): 151 doi: 10.1002/jso.20413
|
6 |
X-L. Xu, Z Q. Ling, S-Z. Chen, B. Li, W-H. Ji, W-M. Mao. The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. Diseases of the Esophagus 2014; 27(1): 79 doi: 10.1111/dote.12024
|
7 |
Chen Huang, Lin Yang, Zhongfang Li, Jun Yang, Junjie Zhao, Xu Dehui, Liying Liu, Quanli Wang, Tusheng Song. Detection of CCND1 amplification using laser capture microdissection coupled with real-time polymerase chain reaction in human esophageal squamous cell carcinoma. Cancer Genetics and Cytogenetics 2007; 175(1): 19 doi: 10.1016/j.cancergencyto.2007.01.003
|
8 |
Pooja Ganguly, Niladri Ganguly. Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins. VirusDisease 2015; 26(3): 105 doi: 10.1007/s13337-015-0259-7
|
9 |
K.‐F. Hung, C.‐S. Chang, C.‐J. Liu, M.‐T. Lui, C.‐Y. Cheng, S.‐Y. Kao. Differential expression of E‐cadherin in metastatic lesionscomparing to primary oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 2006; 35(10): 589 doi: 10.1111/j.1600-0714.2006.00474.x
|
10 |
An-Guo Chen, Zai-Cheng Yu, Xin-Feng Yu, Wen-Feng Cao, Fang Ding, Zhi-Hua Liu. Overexpression of Ets-like protein 1 in human esophageal squamous cell carcinoma. World Journal of Gastroenterology 2006; 12(48): 7859-7863 doi: 10.3748/wjg.v12.i48.7859
|
11 |
Ning Li, Xiaobing Chen, Xiangbin Wan, Suxia Luo, Lili Han, Mengqiang Zhou, Dengwen Yin, Li Zhang. Relationship between expression of CEA, E-cadherin and liver metastasis in colorectal cancer. Chinese Journal of Clinical Oncology 2008; 5(6): 429 doi: 10.1007/s11805-008-0429-0
|
12 |
Raul S. Gonzalez, Sarah C. Shulman, Howard M. Katzenstein, Charlotte K. Steelman, Mark L. Wulkan, Carlos R. Abramowsky, Cynthia Cohen, Gigi K. Davis, Bahig M. Shehata. Colorectal Adenocarcinoma: A Pediatric Case Review with a Focus on Mismatch Repair Gene Mutations and E-Cadherin Expression. Pediatric and Developmental Pathology 2012; 15(3): 192 doi: 10.2350/11-04-1015-OA.1
|
13 |
Marianthi Kyrodimou, Dimitrios Andreadis, Angeliki Drougou, Elsa P. Amanatiadou, Lefteris Angelis, Calypso Barbatis, Apostolos Epivatianos, Ioannis S. Vizirianakis. Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma. Clinical Oral Investigations 2014; 18(1): 199 doi: 10.1007/s00784-013-0937-z
|
14 |
Akira Ooki, Keishi Yamashita, Nobuyuki Kobayashi, Natsuya Katada, Shinichi Sakuramoto, Shiroh Kikuchi, Masahiko Watanabe. Lymph Node Metastasis Density and Growth Pattern as Independent Prognostic Factors in Advanced Esophageal Squamous Cell Carcinoma. World Journal of Surgery 2007; 31(11): 2184 doi: 10.1007/s00268-007-9198-9
|
15 |
Seung Hun Chae, Han Sun Kim, Jae Man Kim, Sang Hee Lee, Sung Ook Jo, Mi Keung Lee, Wan Jo Jung, Ho Jun Lee. Expression of Alpha-catenin/E-cadherin and Clinical Significance of Metastatic Factors in Stage III Advanced Colon Cancer. Journal of the Korean Society of Coloproctology 2009; 25(5): 334 doi: 10.3393/jksc.2009.25.5.334
|
16 |
Rohinton S. Tarapore, Jonathan P. Katz. Molecular Pathology of Neoplastic Gastrointestinal Diseases. Molecular Pathology Library 2013; 7: 53 doi: 10.1007/978-1-4614-6015-2_4
|
17 |
Adam Elzagheid, Annika Ålgars, Riyad Bendardaf, Hanan Lamlum, Raija Ristamaki, Yrjo Collan, Kari Syrjanen, Seppo Pyrhonen. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World Journal of Gastroenterology 2006; 12(27): 4304-4309 doi: 10.3748/wjg.v12.i27.4304
|
18 |
Chun-Yang Zhang, Ren-Ke Li, Yu Qi, Xiang-Nan Li, Yang Yang, Dong-Lei Liu, Jia Zhao, Deng-Yan Zhu, Kai Wu, Xu-Dong Zhou, Song Zhao. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial–mesenchymal transition. Cell Biology and Toxicology 2016; 32(5): 391 doi: 10.1007/s10565-016-9341-1
|
19 |
Hong-Chun Liu, Yi Zhang, Xli-Lin Wang, Wang-Sen Qin, Yu-Han Liu, Lan Zhang, Chang-Lian Zhu. Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2013; 67(8): 751 doi: 10.1016/j.biopha.2013.04.004
|
20 |
Li-Qiang Qian, Xia-Qin Li, Peng-Hui Ye, Hao-Yuan Su, Gang Wang, Yan Liu, Gen-Hai Shen, Quan-Gen Gao. Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. Oncology Letters 2017; 14(4): 4897 doi: 10.3892/ol.2017.6790
|
21 |
Xiaojuan Zhao, Ruben Y. Gabriëls, Wouter T. R. Hooghiemstra, Marjory Koller, Gert Jan Meersma, Manon Buist-Homan, Lydia Visser, Dominic J. Robinson, Anna Tenditnaya, Dimitris Gorpas, Vasilis Ntziachristos, Arend Karrenbeld, Gursah Kats-Ugurlu, Rudolf S. N. Fehrmann, Wouter B. Nagengast. Validation of Novel Molecular Imaging Targets Identified by Functional Genomic mRNA Profiling to Detect Dysplasia in Barrett’s Esophagus. Cancers 2022; 14(10): 2462 doi: 10.3390/cancers14102462
|
22 |
Wei He, Zhihui Wang, Qi Wang, Qingxia Fan, Chengcao Shou, Junsheng Wang, Karl-Erik Giercksky, Jahn M Nesland, Zhenhe Suo. Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-426
|
23 |
Mingchen Zhu, Yijun Xu, Xuelian Mao, Yanfang Gao, Lijia Shao, Feng Yan. Overexpression of Metastasis-Associated in Colon Cancer-1 Associated with Poor Prognosis in Patients with Esophageal Cancer. Pathology & Oncology Research 2013; 19(4): 749 doi: 10.1007/s12253-013-9638-9
|
24 |
Line V. Hansen, Ole D. Lærum, Martin Illemann, Boye S. Nielsen, Michael Ploug. Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. International Journal of Cancer 2008; 122(4): 734 doi: 10.1002/ijc.23082
|
25 |
Jacqueline M. Benjamin, W. James Nelson. Bench to bedside and back again: Molecular mechanisms of α-catenin function and roles in tumorigenesis. Seminars in Cancer Biology 2008; 18(1): 53 doi: 10.1016/j.semcancer.2007.08.003
|
26 |
Zackie Aktary, Manijeh Pasdar. Plakoglobin: Role in Tumorigenesis and Metastasis. International Journal of Cell Biology 2012; 2012: 1 doi: 10.1155/2012/189521
|
27 |
Hong-Xu Liu, Yu Li, Xue-Dong Jiang, Hong-Nian Yin, Lin Zhang, Yu Wang, Jun Yang. Mutation screening of mismatch repair gene Mlh3 in familial esophageal cancer. World Journal of Gastroenterology 2006; 12(33): 5281-5286 doi: 10.3748/wjg.v12.i33.5281
|
28 |
Xiaowei Jia, Bingci Liu, Xianglin Shi, Meng Ye, Fengmei Zhang, Haifeng Liu. Roles of the ERK, JNK/AP‐1/cyclin D1–CDK4 pathway in silica‐induced cell cycle changes in human embryo lung fibroblast cells. Cell Biology International 2011; 35(7): 697 doi: 10.1042/CBI20100298
|
29 |
Bahig M. Shehata, Sarah S. Kappa. Rare Tumors in Children and Adolescents. Pediatric Oncology 2022; : 207 doi: 10.1007/978-3-030-92071-5_23
|
30 |
Xiao Xia Wang, Rong Liu, Shun Qian Jin, Fei Yue Fan, Qi Min Zhan. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line. Cell Research 2006; 16(4): 356 doi: 10.1038/sj.cr.7310046
|
31 |
J. Zhao, L. Li, S. Wei, Y. Gao, Y. Chen, G. Wang, Z. Wu. Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis. Diseases of the Esophagus 2012; 25(6): 520 doi: 10.1111/j.1442-2050.2011.01278.x
|
32 |
Charlotte Parberry‐Clark, Jonathan P Bury, Simon S Cross, Steve J Winder. Loss of dystroglycan function in oesophageal cancer. Histopathology 2011; 59(2): 180 doi: 10.1111/j.1365-2559.2011.03930.x
|
33 |
Wang-Kai Fang, Wei Gu, En-Min Li, Zhi-Yong Wu, Zhong-Ying Shen, Jin-Hui Shen, Jian-Yi Wu, Feng Pan, Zhuo Lv, Xiu-E Xu, Qiao Huang, Li-Yan Xu. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor. Human Pathology 2010; 41(10): 1456 doi: 10.1016/j.humpath.2010.04.003
|
34 |
Bahig M. Shehata, Sarah C. Shulman. Rare Tumors In Children and Adolescents. Pediatric Oncology 2012; : 245 doi: 10.1007/978-3-642-04197-6_29
|
35 |
TAKAHIRO SHIBATA, YOICHI MATSUO, TOMOYA SHAMOTO, TAKAHISA HIROKAWA, KEN TSUBOI, HIROKI TAKAHASHI, HIDEYUKI ISHIGURO, MASAHIRO KIMURA, HIROMITSU TAKEYAMA, HIROSHI INAGAKI. Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma. Oncology Reports 2013; 29(6): 2127 doi: 10.3892/or.2013.2406
|
36 |
Yvonne Chung, Alfred K. Y. Lam, John M. Luk, Simon Law, Kwok-Wah Chan, Ping-Yin Lee, John Wong. Altered E-Cadherin Expression and p120 Catenin Localization in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 2007; 14(11): 3260 doi: 10.1245/s10434-007-9511-8
|
37 |
Kriebashne S. Nair, Richard Naidoo, Runjan Chetty. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma. Human Pathology 2006; 37(2): 125 doi: 10.1016/j.humpath.2005.10.009
|
38 |
Jianming Zhang, Wei Zhang, Ping Gao, Yanqiu Li, Changyi Li, Sakan Maeda. Expression of E-cadherin in oral squamous cell carcinoma is associated with clinical prognosis. Chinese Journal of Clinical Oncology 2006; 3(3): 181 doi: 10.1007/s11805-006-0115-z
|
39 |
Emma M. Gallagher, Deirdre M. O'Shea, Patricia Fitzpatrick, Michèle Harrison, Breege Gilmartin, Jenny A. Watson, Trevor Clarke, Martin O. Leonard, Aloysius McGoldrick, Maria Meehan, Chanel Watson, Fiona Furlong, Patrick O'Kelly, John M. Fitzpatrick, Peter A. Dervan, Anthony O'Grady, Elaine W. Kay, Amanda McCann. Recurrence of Urothelial Carcinoma of the Bladder: A Role for Insulin-Like Growth Factor-II Loss of Imprinting and Cytoplasmic E-Cadherin Immunolocalization. Clinical Cancer Research 2008; 14(21): 6829 doi: 10.1158/1078-0432.CCR-08-0577
|
40 |
Junzo Kudo, Tadashi Nishiwaki, Nobuhiro Haruki, Hideyuki Ishiguro, Yasuyuki Shibata, Yukio Terashita, Hironori Sugiura, Noriyuki Shinoda, Masahiro Kimura, Yoshiyuki Kuwabara, Yoshitaka Fujii. Aberrant nuclear localization of β-catenin without genetic alterations in β-catenin or Axin genes in esophageal cancer. World Journal of Surgical Oncology 2007; 5(1) doi: 10.1186/1477-7819-5-21
|
41 |
Xiaojuan Zhao, Qingfeng Huang, Marjory Koller, Matthijs D. Linssen, Wouter T. R. Hooghiemstra, Steven J. de Jongh, Marcel A. T. M. van Vugt, Rudolf S. N. Fehrmann, Enmin Li, Wouter B. Nagengast. Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy. International Journal of Molecular Sciences 2021; 22(17): 9270 doi: 10.3390/ijms22179270
|
42 |
Shin SAITO, Yoshinori HOSOYA, Kazue MORISHIMA, Takashi UI, Hidenori HARUTA, Kentaro KURASHINA, Yoshiyuki MEGURO, Toru ZUIKI, Naohiro SATA, Hirofumi FUJII, Daisuke MATSUBARA, Toshiro NIKI, Alan T. LEFOR, Yoshikazu YASUDA. A clinicopathological and immunohistochemical study of gastric cancer with squamous cell carcinoma components: A clinically aggressive tumor. Journal of Digestive Diseases 2012; 13(8): 407 doi: 10.1111/j.1751-2980.2012.00610.x
|
43 |
Carolina Bonilla, Tshela Mason, Layron Long, Chiledum Ahaghotu, Weidong Chen, Aiqiu Zhao, Aoua Coulibaly, Frankly Bennett, William Aiken, Trevor Tullock, Kathleen Coard, Vincent Freeman, Rick A. Kittles. E‐cadherin polymorphisms and haplotypes influence risk for prostate cancer. The Prostate 2006; 66(5): 546 doi: 10.1002/pros.20374
|
44 |
Yulin Song, Qixin Zheng, Yongchao Wu, Xiaodong Guo. Two-dimensional effects of hydrogel self-organized from IKVAV-containing peptides on growth and differentiation of NSCs. Journal of Wuhan University of Technology-Mater. Sci. Ed. 2009; 24(2): 186 doi: 10.1007/s11595-009-2186-1
|